Robert J Carpenter insider trades

Open-market stock purchases and sales by Robert J Carpenter, Director at Immuneering Corp, from SEC Form 4 filings since Jun 16, 2010.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -69%.

Recent trades

DateStockTradeValue
Jun 11, 2026IMRX Immuneering CorpBought (not open market)—

Companies traded

  • IMRX Immuneering Corp: 1 buy, last Jun 11, 2026
  • GENZ Genzyme Corp: other filings, last Apr 4, 2011

Get free alerts when Robert J Carpenter files a new trade →